A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors
Titel:
A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors
Auteur:
Limentani, Steven A. Campone, Mario Dorval, Thierry Curigliano, Giuseppe Boer, Richard de Vogel, Charles White, Shane Bachelot, Thomas Canon, Jean-Luc Disis, Mary Awada, Ahmad Berlière, Martine Amant, Frédéric Levine, Ellis Burny, Wivine Callegaro, Andrea Sousa Alves, Pedro Miguel de Louahed, Jamila Brichard, Vincent Lehmann, Frédéric F.